Scotiabank Comments on Nutrien’s FY2026 Earnings (NYSE:NTR)

Nutrien Ltd. (NYSE:NTR) – Research analysts at Scotiabank decreased their FY2026 EPS estimates for Nutrien in a research note issued on Thursday, October 22nd. Scotiabank analyst B. Isaacson now anticipates that the company will post earnings per share of $4.62 for the year, down from their previous estimate of $4.89. Scotiabank currently has a “Sector Outperform” rating and a $80.00 price objective on the stock. The consensus estimate for Nutrien’s current full-year earnings is $4.56 per share.

NTR has been the subject of several other research reports. Jefferies Financial Group reissued a “hold” rating and issued a $71.00 price target on shares of Nutrien in a research note on Monday, October 12th. KeyCorp initiated coverage on shares of Nutrien in a research note on Thursday, September 10th. They set a “sector weight” rating and a $73.00 price objective on the stock. Barclays reduced their price objective on shares of Nutrien from $81.00 to $78.00 and set an “overweight” rating for the company in a report on Monday, August 10th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $85.00 target price on shares of Nutrien in a research report on Friday, September 18th. Finally, set a $85.00 target price on shares of Nutrien and gave the company an “outperform” rating in a research note on Monday, October 5th. Sixteen equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $79.80.

Nutrien Stock Down 2.0%

NTR opened at $68.37 on Monday. The stock’s 50 day moving average price is $73.24 and its 200 day moving average price is $70.75. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.39 and a quick ratio of 0.86. The stock has a market cap of $32.55 billion, a P/E ratio of 14.90, a P/E/G ratio of 0.76 and a beta of 0.68. Nutrien has a 12 month low of $53.03 and a 12 month high of $85.36.

Nutrien (NYSE:NTR) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $2.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.70 by ($0.09). Nutrien had a return on equity of 8.88% and a net margin of 8.44%. The business had revenue of $10.81 billion for the quarter, compared to analyst estimates of $10.44 billion. During the same quarter in the prior year, the firm posted $2.65 earnings per share. The business’s quarterly revenue was up 3.6% on a year-over-year basis.

Nutrien Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 16th. Stockholders of record on Tuesday, September 29th were given a dividend of $0.55 per share. The ex-dividend date was Tuesday, September 29th. This represents a $2.20 annualized dividend and a dividend yield of 3.2%. Nutrien’s dividend payout ratio (DPR) is 44.53%.

Hedge Funds Weigh In On Nutrien

Several hedge funds have recently made changes to their positions in the business. Bryn Mawr Trust Advisors LLC acquired a new stake in shares of Nutrien during the 2nd quarter valued at $8,363,000. Engineers Gate Manager LP increased its position in shares of Nutrien by 665.4% in the second quarter. Engineers Gate Manager LP now owns 67,888 shares of the company’s stock worth $4,274,000 after acquiring an additional 59,018 shares in the last quarter. Andra AP fonden raised its holdings in shares of Nutrien by 419.9% during the second quarter. Andra AP fonden now owns 141,395 shares of the company’s stock valued at $8,901,000 after acquiring an additional 114,200 shares during the period. BlackRock Inc. acquired a new stake in shares of Nutrien during the second quarter valued at approximately $220,942,000. Finally, Nykredit A S acquired a new stake in shares of Nutrien during the second quarter valued at approximately $8,980,000. Institutional investors and hedge funds own 63.10% of the company’s stock.

About Nutrien